How early nerve development affects smell, puberty, and fertility
Official title: Molecular Mechanisms Underlying Terminal Nerve Development, GnRH-1 Neuronal Migration, and Olfactory Bulb Formation in Normal and Pathological Conditions
Funded at State University of New York at Albany · NIH-11235887 · Data updated 2026-11-12
Researchers are looking at how early nerve pathways guide the brain cells that control puberty and fertility in people with conditions like Kallmann syndrome and related infertility.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Albany NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project start | November 15, 2024 |
| Project end | October 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $340,508 |
| NIH project number | 5R01HD114827-02 |
| Project ID | NIH-11235887 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with Kallmann syndrome, unexplained hypogonadotropic hypogonadism, delayed puberty, or combined smell loss and reproductive problems would be the most relevant patient groups for this line of research.
✕Less likely to help
Patients whose infertility has clearly different causes (for example tubal blockage, non-hormonal sperm issues, or purely ovarian failure unrelated to GnRH signaling) are unlikely to benefit directly from these findings.
What this research studies
This work looks at the nerve pathway that GnRH-1 neurons use to travel from the nose into the brain and how that process affects the formation of the sense-of-smell system. The team will use genetic analyses, cell and tissue experiments, and animal models to follow those pioneer neurons and test how specific genes influence their growth and guidance. They aim to distinguish genes that build the terminal nerve from those that make smell-sensing neurons, and to see how mutations linked to Kallmann syndrome or idiopathic hypogonadotropic hypogonadism disrupt these steps. Results are intended to clarify why some people have both smell loss and delayed puberty or infertility.
Why it matters
Potential benefit: If successful, this research could improve understanding of causes of Kallmann syndrome and related forms of hypogonadotropic hypogonadism, which may guide future genetic testing and targeted therapies.
How similar studies have gone: Prior genetic and animal-model work has linked many genes to GnRH neuron migration and Kallmann syndrome, so this project builds on established findings while probing a novel nerve pathway and specific cellular mechanisms.
Where this research is happening
-
State University of New York at Albany
Albany, United States Active
Researchers
- Principal investigator: Forni, Paolo E — State University of New York at Albany
- Study coordinator: Forni, Paolo E
Related research
Other NIH-funded projects on the same topics.
-
Cross-disease small molecule therapy for CAG expansion spinocerebellar ataxias
A new NIH grant is exploring whether existing and natural small molecules can lower harmful CAG RNA and proteins across several spinocerebellar ataxias to help people with these conditions.
-
New small molecule therapeutics to help myotonic dystrophy
A new NIH-funded project tests specially designed small molecules to lower harmful RNA activity in myotonic dystrophy and related diseases, aiming to reduce disease-driving RNA effects.
-
Biofilm structure and its role in the start of gum disease
A researchers team will study how tiny communities of bacteria at the gumline interact with the mouth’s tissues to spark inflammation that leads from healthy gums to periodontal disease.
-
Understanding how unusual RNA translation happens in neurological diseases
Researchers are studying how RNAs can start making proteins in unexpected ways in neurodegenerative diseases, which could reveal new targets for therapy.
-
Early-life neighborhood redlining and lifetime mortality in a historical cohort
This project looks at whether growing up in areas graded or disinvested by HOLC in the 1930s affects mortality later in life for people born in 1930–1940.
-
Activating PTP1B and Other Phosphatases with Small Molecules
A safety-focused, patient-friendly look at a project that aims to turn on natural enzymes in our cells to help correct harmful signals in diseases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.